Details of the Drug

General Information of Drug (ID: DM4CZHF)

Drug Name

MB-11316

Indication

Disease Entry	ICD 11	Status	REF
Injury	NA00-ND5Z	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	Clinical pipeline report, company report or official report of Mazence Inc.